Pancreatic Neuroendocrine Tumor (NET)
Pancreatic Neuroendocrine Tumors (NETs) are rare, yet impactful, forms of cancer that develop in the neuroendocrine cells of the pancreas. Unlike more common pancreatic cancers, such as adenocarcinoma, which affect the exocrine cells, NETs originate in the hormone-producing cells of the pancreas.
These tumors can vary greatly in their behavior, ranging from slow-growing and benign to aggressive and malignant. Due to their diverse nature, diagnosing and treating Pancreatic NETs require a multidisciplinary approach involving oncologists, surgeons, endocrinologists, and other specialists.
Symptoms of Pancreatic NETs may include abdominal pain, digestive issues, unintended weight loss, changes in blood sugar levels, and hormonal imbalances leading to symptoms such as flushing, diarrhea, or wheezing.
Treatment options for Pancreatic NETs depend on factors such as the tumor’s size, grade, stage, and location. They may include surgery, chemotherapy, radiation therapy, targeted therapy, and hormone therapy. The goal of treatment is to manage symptoms, control tumor growth, and improve overall quality of life for patients.
Despite being rare, Pancreatic NETs present unique challenges and require specialized care. At SRM Foundation, we understand the complexities of this disease and are dedicated to supporting patients and their families through every step of their journey, providing resources, financial assistance, and emotional support to those affected by Pancreatic NETs.
Through awareness, education, and advocacy, we strive to make a difference in the lives of individuals battling Pancreatic Neuroendocrine Tumors, offering hope and assistance in their fight against cancer.
